drugset / Trial / NCT03471767
AXS-05 Phase II Trial on Smoking Behavior
RandomizedParallel-groupDouble-blindTreatment
Summary
This research study is designed with the purpose of evaluating a new drug, combination Dextromethorphan-Bupropion (AXS-05), for its effects on smoking behavior.
Timeline
- Start
- 2018-03-25
- Primary completion
- 2019-03-31
- Completion
- 2019-03-31
Outcome
Missed primary endpoint
registry analysis (other test); AXS-05 vs Bupropion SR; p = 0.15; t-test, 2 sided NCT03471767 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupropion | Small molecule | — | Oral |
| Subject | Dextromethorphan | Unknown | — | Oral |